Merck to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

Featured Story

Merck to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

HUB internationally recognized pioneer in organoid development Acquisition expands Merck’s 2D and 3D cell culture portfolio Organoids part of fastest...

Read More

More from HUB

HUB Organoids Launches IntegriGut Screen: A Breakthrough Service Offering for Inflammatory Bowel Disease (IBD) Drug Discovery and Development

HUB Organoids Launches IntegriGut Screen: A Breakthrough Service Offering for Inflammatory Bowel Disease (IBD) Drug Discovery and Development

Utrecht, Netherlands – 25th Jan 2024 – HUB Organoids (HUB), a global leader and sole proprietor of patient-derived organoid technology...

HUB Organoids Announces New Corporate Strategy and Completes Transition from Foundation to Private Company

HUB Organoids Announces New Corporate Strategy and Completes Transition from Foundation to Private Company

[Utrecht, July 18 2023] — HUB Organoids (HUB), the global leader in the field of patient-derived organoids, is excited to...

FDA Modernization Act 2.0: We welcome the dawn of an organoid era

FDA Modernization Act 2.0: We welcome the dawn of an organoid era

X

Have any questions?

contact us